BioCryst Pharma (BCRX) Tops Q2 EPS by 1c; Sees Increase in Net Operating Cash
Go back to BioCryst Pharma (BCRX) Tops Q2 EPS by 1c; Sees Increase in Net Operating Cash| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.81 -0.78 (7.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.59 | 52 Week High | $10.98 | |||
| Open | $10.59 | 52 Week Low | $1.63 | |||
| Day High | $10.63 | P/E | N/A | |||
| Day Low | $9.70 | EPS | $-0.68 | |||
| Volume | 4,577,416 | |||||
